67 related articles for article (PubMed ID: 17465222)
1. Incadronate induces cell detachment and apoptosis in prostatic PC-3 cells.
Matsunaga S; Iguchi K; Usui S; Hirano K
Anticancer Res; 2007; 27(2):927-32. PubMed ID: 17465222
[TBL] [Abstract][Full Text] [Related]
2. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ
Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051
[TBL] [Abstract][Full Text] [Related]
3. Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
Iguchi K; Nakano T; Usui S; Hirano K
Cancer Lett; 2006 Jun; 237(2):223-33. PubMed ID: 16019130
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation.
Coxon JP; Oades GM; Kirby RS; Colston KW
BJU Int; 2004 Jul; 94(1):164-70. PubMed ID: 15217454
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of caveolin-1 expression by incadronate in PC-3 prostate cells.
Iguchi K; Matsunaga S; Nakano T; Usui S; Hirano K
Anticancer Res; 2006; 26(4B):2977-81. PubMed ID: 16886623
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
[TBL] [Abstract][Full Text] [Related]
9. Effect of incadronate on proliferation of mesenchymal tumor cells with or without activated Ras mutation.
Kawashima H; Ogose A; Hotta T; Ito T; Endo N; Kawashima H; Tamura K; Nakano K
J Exp Clin Cancer Res; 2005 Dec; 24(4):617-24. PubMed ID: 16471325
[TBL] [Abstract][Full Text] [Related]
10. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
11. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
[TBL] [Abstract][Full Text] [Related]
12. The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
Takiguchi S; Nishino Y; Inoue K; Ikeda M; Kataoka Y; Matsusue K; Nishiyama K; Iguchi H
Oncol Rep; 2012 Jul; 28(1):111-6. PubMed ID: 22484715
[TBL] [Abstract][Full Text] [Related]
13. Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein.
Sasaki H; Kotsuji F; Tsang BK
Gynecol Oncol; 2002 May; 85(2):339-50. PubMed ID: 11972398
[TBL] [Abstract][Full Text] [Related]
14. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.
Iguchi K; Tatsuda Y; Usui S; Hirano K
Eur J Pharmacol; 2010 Sep; 641(1):35-40. PubMed ID: 20519142
[TBL] [Abstract][Full Text] [Related]
15. FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells.
Sonoda Y; Yamamoto D; Sakurai S; Hasegawa M; Aizu-Yokota E; Momoi T; Kasahara T
Biochem Biophys Res Commun; 2001 Feb; 281(2):282-8. PubMed ID: 11181042
[TBL] [Abstract][Full Text] [Related]
16. Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway.
Iguchi T; Miyakawa Y; Yamamoto K; Kizaki M; Ikeda Y
Cell Signal; 2003 Jul; 15(7):719-27. PubMed ID: 12742232
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines.
Golubovskaya VM; Gross S; Kaur AS; Wilson RI; Xu LH; Yang XH; Cance WG
Mol Cancer Res; 2003 Aug; 1(10):755-64. PubMed ID: 12939401
[TBL] [Abstract][Full Text] [Related]
18. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
19. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]